Parasitic skin disease leaves thousands scarred in Pakistan's northwest

1 / 3
A leishmaniasis patient shows his arms at a medical store on April 8, 2019. The disease is caused by a parasite injected by the bite of bloodsucking sandflies that can lead to deep ulcers that take months to heal and cause severe scarring, often on the face. (Photo Arab News)
2 / 3
Following the outbreak of leishmaniasis in parts of Pakistan's tribal areas, health officials in Tank, the gateway to the South Waziristan tribal district, carry out anti-mosquito fumigation on April 8, 2019. (Photo Arab News)
3 / 3
A view of the District Headquarters Hospital in Tank where many of Khyber Pakhtunkhwa province's 28,000 patients of leishmaniasis are coming for treatment since the outbreak of the disease in the last six months. (Photo Arab News)
Updated 11 April 2019
Follow

Parasitic skin disease leaves thousands scarred in Pakistan's northwest

  • 28,000 cases of leishmaniasis reported in Khyber Pakhtunkhwa in the last six months
  • Doctors say shortage of medicines has driven number of cases further up in the last few weeks

TANK, Pakistan: It began with a tiny lesion on Muhammad Hamza’s cheek last month. Soon, most of the 12-year-old boy’s body was covered in sores the size of large coins and speckled with blood. He complained that he had difficulty breathing and eating.
A doctor in Pakistan’s South Waziristan tribal district diagnosed Hamza with leishmaniasis, a disease caused by a parasite injected by the bite of bloodsucking sandflies that can lead to deep ulcers that take months to heal and cause severe scarring, often on the face.
In the last six months, 28,000 cases of the disease have been reported in Pakistan’s northwestern Khyber Pakhtunkhwa province, according to figures from the ministry of health. At least 5,000 of these cases have emerged in the erstwhile semi-autonomous tribal regions that were merged into Khyber Pakhtunkhwa last year after a parliamentary vote.
Previously, the Federally Administered Tribal Areas, as they used to be called, were governed for over 150 years by colonial era tribal laws and provided a haven for militants, gun runners and drug smugglers. Without provincial status, the area also suffered from a lack of national investment in education, telecommunication and, above all, health care.
Doctors from the area said health authorities were ill-prepared to control the outbreak of leishmaniasis and a shortage of medicines had driven the number of cases further up in the last few weeks. Health Secretary Jamil Farooq said the World Health Organization had donated 10,000 glucantime injections, but the shortage persisted. WHO officials could not be reached for comment.
Farooq said the provincial government had adopted a two-pronged policy to tackle the disease: preemptive measures such as fumigation and curative treatment with a course of injections, or by cauterizing sores to kill the parasites.
“The dilemma is that signs of leishmaniasis appear after three months,” Farooq said, adding that the government was also planning to launch an awareness campaign about the spread of the disease and the effective use of insecticides.
The sandflies that spread the parasites are carried by animals as well as people. They often breed on waste land and in rubbish and infest cracks and crevices in people’s homes. From there, they emerge during night hours from late spring to autumn and bite exposed parts of the body like ears, noses, cheeks and hands while people sleep, Dr. Rahim Dawar, the top health official of the South Waziristan tribal district, explained. 
Nasib Shah Shinwari, a tribesman from Khyber tribal district where the largest number of leishmaniasis cased have been reported, said his nine year old daughter contracted the disease six months ago but was now recovering after starting a course of injections.
“Yes, we are getting injections from the District Headquarters Hospital in Landikotal,” he said, referring to the main town in Khyber tribal district. “Sometimes the hospital staff complain of medicine shortage. But she is recovering.”
Hamza’s father Ghulam Rasool said he was unable to find the required leishmaniasis medicines at the District Headquarters Hospital in Tank, the gateway district to the volatile South Waziristan, and had to purchase them at a higher price from a private medical store.
Tribal elder Malik Qabil Khan said locals were planning to convene a jirga, or village assembly, next week to chalk out a strategy on how to tackle the outbreak and build pressure on the administration.


IMF board to approve Pakistan reviews today ‘if all goes well,’ say officials

Updated 08 December 2025
Follow

IMF board to approve Pakistan reviews today ‘if all goes well,’ say officials

  • IMF’s executive board is scheduled to meet today to discuss the disbursement of $1.2 billion
  • Economists say the money will boost Pakistan’s forex reserves, send positive signals to investors

KARACHI: The International Monetary Fund’s (IMF) executive board is scheduled to meet today, Monday, to approve the release of about $1.2 billion for Pakistan under the lender’s two loan facilities, said IMF officials who requested not to be named.

The IMF officials confirmed the executive board was going to decide on the Fund’s second review under the $7 billion Extended Fund Facility (EFF) and first review under the $1.4 billion Resilience and Sustainability Facility (RSF), a financing tool that provides long-term, low-cost loans to help countries address climate risks.

“The board meeting will be taking place as planned,” an IMF official told Arab News.

“The board is on today yes as per the calendar,” said another.

A well-placed official at Pakistan’s finance ministry also confirmed the board meeting was scheduled today to discuss the next tranche for Pakistan.

The IMF executive board’s meeting comes nearly two months after a staff-level agreement (SLA) was signed between the two sides in October.

Procedurally, the SLAs are subject to approval by the executive board, though it is largely viewed as a formality.

“If all goes well, the reviews should pass,” said the second IMF official.

On approval, Pakistan will have access to about $1 billion under the EFF and about $200 million under the RSF, the IMF said in a statement in October after the SLA.

The fresh transfer will bring total disbursements under the two arrangements to about $3.3 billion, it added.

Experts see smooth sailing for Pakistan in terms of the passing of the two reviews, saying the IMF disbursements will help the cash-strapped nation to strengthen its balance of payments position.

Samiullah Tariq, group head of research at Pakistan Kuwait Investment Company Limited, said the IMF board’s approval will show that Pakistan’s economy is on the right path.

“It obviously will help strengthen [the country’s] external sector, the balance of payments,” he told Arab News.

Until recently, Pakistan grappled with a macroeconomic crisis that drained its financial resources and triggered a balance of payments crisis.

Pakistan has reported financial gains since 2022, recording current account surpluses and taming inflation that touched unprecedented levels in mid-2023.

Economists also viewed the IMF’s bailout packages as crucial for cash-strapped Pakistan, which has relied heavily on financing from bilateral partners such as Saudi Arabia, China and the United Arab Emirates, as well as multilateral lenders.

Saudi Arabia, through the Saudi Fund for Development, last week extended the term of its $3 billion deposit for another year to help Pakistan boost its foreign exchange reserves, which stood at $14.5 billion as of November 28, according to State Bank of Pakistan statements.

“In our view this [IMF tranche] will be approved,” said Shankar Talreja, head of research at Karachi-based brokerage Topline Securities Limited.

“This will help strengthen reserves and will eventually help a rating upgrade going forward,” he said.

The IMF board’s nod, Talreja said, would also send a signal to the international and local investors regarding the continuation of the reform agenda by Pakistan’s government.